EZH2 as a Potential Target for NAFLD Therapy
Non-alcoholic fatty liver disease (NAFLD) is a complex disease that is affected by genetic predisposition and epigenetic modification. Deregulation of epigenetic pathways is now recognized as a frequent event in NAFLD, and understanding the mechanistic roles of these epigenetic factors may lead to n...
Main Authors: | Hyun Jung Lim, Mirang Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/22/8617 |
Similar Items
-
EZH2 Down-Regulation Exacerbates Lipid Accumulation and Inflammation in in Vitro and in Vivo NAFLD
by: Serena Vella, et al.
Published: (2013-12-01) -
Comparison between NAFLD fibrosis score and retinoic acid serum level in NAFLD
by: Ahmed Samir Allam, et al.
Published: (2020-01-01) -
Dual Role of MicroRNAs in NAFLD
by: Valerio Nobili, et al.
Published: (2013-04-01) -
Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD)
by: Francesco Vizzutti;, et al.
Published: (2009-04-01) -
Judicious Use of Lipid Lowering Agents in the Management of NAFLD
by: Umair Iqbal, et al.
Published: (2018-09-01)